Advanced search
Publication Cover
Expert Review of Obstetrics & Gynecology Volume 8, 2013 - Issue 6
Journal homepage
47
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Unintended pregnancy and the role of long-acting reversible contraception

Monica N ModiDepartment of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USACorrespondence[email protected]
,
Ryan J HeitmannProgram in Reproductive and Adult Endocrinology, National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
&
Alicia Y ArmstrongProgram in Reproductive and Adult Endocrinology, National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
Pages 549-558 | Published online: 10 Jan 2014

References

  • Santelli JS, Rochat R, Hatfield-Timajchy K et al. The measurement and meaning of unintended pregnancy. Perspect. Sex. Reprod. Health. 35(2), 94–101 (2003).
  • Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trend and outcomes. Stud. Fam. Plann. 41(4), 241–250 (2010).
  • Singh S. Adding it Up: The Cost and Benefits of Investing in Family Planning and Maternal and Newborn Health. Institute and UNFPA, Guttmacher, NY, USA (2009).
  • World Health Organization. Unsafe abortion: Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. World Health Organization, Genevea, CH (2011).
  • Sedgh G, Hussain R, Bankole A, Susheela Singh. (2007) Women with an Unmet Need for Contraception in the Developing Countries and Their Reasons for Not Using a Method ( Report Number 37). Guttmacher Institute (2007).
  • Finer LB, Henshaw S. Dispartities in rates of unintended pregnancy in the United States, 1994 and 2001. Persp. Sex. Reprod. Health. 38(2), 90–96 (2006).
  • Guttermacher Institute. Facts on Unintended Pregnancy in the United States Guttmacher Institute, Guttermacher, NY, USA (2012).
  • Finer LB, Zolna MR. Unintended Pregnancies in the United States: incidence and disparities: 2006. Contraception 84(5), 478–485 (2011).
  • Martin JA, Hamilton BD, Ventura SJ et al. Births: final data for 2009. National Vital Stat Report 2011. 60(1), (2011).
  • Jones J, Mosher W, Daniels K. Current Contraceptive Use in the United States, 2006–2010, and Changes in Patterns of use Since 1995. National Health Statistics Report. 60, (2012).
  • Gold RB, Sonfield A, Richards CL, Frost JJ. Next Steps for America’s Family Planning Program: Leveraging the Potential of Medicaid and Title X in an Evolving Health Care System. Guttmacher Institute, Guttermacher, NY, USA (2009).
  • Center for Disease Control and Prevention. Prepregnancy contraceptive use among teens with unintended pregannacies resulting in live births- pregnancy risk assessment monitoring system (PRAMS) 2004-2008. MMWR Morb. Mortal. Wkly. Rep. 61(2), 25–29 (2012).
  • Debiec KE, Paul KJ, Mitchell CM, Hitti JE. Inadequate prenatal care and risk of preterm delivery among adolescents: a retrospective sturdy over 10 years. Am. J. Obstet. Gynecol. 203(2), 122 (2010).
  • Bachrach C, Compernolie LP, Helfferich C, Lindahl K, Van der Vlugt I, Unplanned Pregnancy and Abortion in the United States and Europe: Why so Different, in The National Campaign to Prevent Teen and Unplanned Pregnancy (2012).
  • Shunmann C, Glasier A. Measuring pregnancy intention and its relationship with contraceptive use among women undergoing therapeutic abortion. Contraception. 73(5), 520–524 (2006).
  • Lakha F, Glasier A. Unintended Pregnancy and use of Emergency Contraception among a large cohort of women attending for antenatal care or abortion in Scotland. The Lancet. 368(9549), 1782–1787 (2006).
  • Lader D. Opinion survey report No. 41: Contraception and Sexual Health 2008/2009, Office of National Statistics, (2009).
  • Goto A, Yasumura S, Reich MR, Fukao A. Factors associated with unintended pregnancy in Yamagata Japan. Social Sci. Med. 54(7), 1065–1079 (2002).
  • Sato R, Iwasawa M. Contraceptive use and induced abortions in Japan: How is it so unique among the developed countries. The Jpn J. Popul. 4(1), (2006).
  • The Population Policy Data Bank: Japan, Population Division of the Deptartment of Economics and Social Affairs of the United Nations Secretat, 2000.
  • Kato M. Abortion still key birth control. The Japan Times, 20th October (2009).
  • Unicef. Countdown to Zero: Elimination of New HIV infections Among Children by 2015 And Keeping Their Mothers Alive: Chad. UNAIDS, Geneva, CH (2011).
  • Unicef. Nepal Country programme document 2013–2017, in Unicef 2012 annual session, second regular session of the Executive Board2012. United Nations, New York, NY, USA (2012).
  • Cobb L, Putney P, Rochat R, Solo J, Buono N, Dunlop J, Vandenbroucke M. Global Evaluation of USAID's Post abortion Care Programme. The Population Technical Assistance. Washington, DC, USA (2001).
  • Dahal GP, Padmadas SS, Hinde PA. Fertility-limiting behavior and contraceptive choice among men in nepal. Int. Fam. Plan. Perspect. 34(1), 6–14 (2008).
  • Maternal mortality Fact Sheet N. 348, World Health Organization, 2012.
  • Ehrle N, Sarker M. Emergency contraceptive pills, knowledge and attitudes of pharmacy personnel in managua, nicaragua. Int. Perspect. Sex. Reprod Health. 37(2), 67–74 (2011).
  • Gilda Sedgh, Hussain R, Bankole A, Singh S. Women with an Unmet Need for Contraception in Developing Countries and Their Reasons for Not Using a Method. (2007).
  • United Nations. World Contraceptive Use 2009. United Nations Department of Economic and Social Affairs. (2009).
  • Jean Cristophe F, Saliku T, Ochako R. Unintended Pregnancy and Future Contraceptive Use among Slum and Non-slum in Nairobi. African Population and Health Research Center, Nairobi, KE (2011).
  • Unsafe abortions: eight maternal deaths every hour. Lancet. 374(9698), 1301 (2009).
  • Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital. Health. Stat. 23. (29), 1–44 (2010).
  • Trussell J. Contraceptive failure in the United States. Contraception. 83(5), 397–404 (2011).
  • Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility. (8th Edition) Volume 8 Lipincott, Williams and Wilkins, Philadelphia, USA (2011).
  • Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am. J. Obstet. Gynecol. 181(5 Pt 1), 1263–1269 (1999).
  • American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet. Gynecol. 118(1), 184–96 (2011).
  • Hatcher RA, T.James, Nelson AL, Cates W, Stewart F, Koal D, Contraceptive Technology. ( 19th Edition):. Ardent Media, New York, NY, USA (2007).
  • Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br. J. Obstet. Gynaecol. 97(8), 690–694 (1990).
  • Sivin I, Stern J, Coutinho E et al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. Contraception 44(5), 473–480 (1991).
  • Diaz S, Pavez M, Moo-Young AJ, Bardin CW, Crozatto HB. Clinical trial with 3-keto-desogestrel subdermal implants. Contraception. 44(4), 393–408 (1991).
  • Makarainen L, van Beek A, Tuomivaara L, Asplund B, Coelingh BH. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil. Steril. 69(4), 714–721 (1998).
  • Davies GC, Feng LX, Newton JR, Van Beek A, Coelingh-Bennink HJ. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel. Contraception 47(3), 251–261 (1993).
  • Croxatto HB. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception 65(1), 21–27 (2002).
  • Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception. 67(2), 87–91 (2003).
  • Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception. 65(2), 129–132 (2002).
  • Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet. Gynecol. Scand. 78(8), 716–721 (1999).
  • Gardner FJ, Konje JC, Abrams KR et al. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial. Lancet. 356(9243), 1711–1717 (2000).
  • Varila E, Wahlstrom T, Rauramo I. A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy. Fertil. Steril. 76(5), 969–973 (2001).
  • Chan SS, Tam WH, Yeo W et al. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. BJOG. 114(12), 1510–1515 (2007).
  • Gardner FJ, Konje JC, Bell SC et al. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial. Gynecol. Oncol. 114(3), 452–456.
  • Vereide AB, Kaino T, Sager G, Arnes M, Orbo A. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia. Gynecol. Oncol. 101(2), 214–223 (2006).
  • Vereide AB, Arnes M, Straume B, Maltau JM, Orbo A. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecol. Oncol. 91(3), 526–533 (2003).
  • Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 84(5), 478–485 (2011).
  • Zhang XJ, Wang GY, Shen Q et al. Current status of contraceptive use among rural married women in Anhui Province of China. BJOG. 116(12), 1640–1645 (2009).
  • Kost K, Singh S, Vaughan B, Bankole A et al. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 77(1), 10–21 (2008).
  • Jones RK, Darroch JE, Henshaw SK. Contraceptive use among U.S. women having abortions in 2000–2001. Perspect. Sex. Reprod. Health. 34(6), 294–303 (2002).
  • French R, Van Vliet H, Cowan F et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane. Database Syst. Rev. 3, CD001776 (2004).
  • Park HY, Rodriguez MI, Hulett D, Darney PD, Thiel de Bocanegra H. Long-acting reversible contraception method use among Title X providers and non-Title X providers in California. Contraception 86(5), 557–561 (2012).
  • Fanarjian N, Drostin C, Garrett J, Montalvo A. Does the provision of free intrauterine contraception reduce pregnancy rates among uninsured low-income women? A cohort study: a two North Carolina clinics. Contraception 85(2), 160–165 (2012).
  • Winner B, Peipert JF, Zhao Q et al. Effectiveness of long-acting reversible contraception. N. Engl. J. Med. 366(21), 1998–2007 (2012).
  • Singh S, Darroch JE, Ashford LS, Vlassof M. Adding It Up: The Costs And Benefits Of Investing In Family Planning And Maternal And Newborn Health. Guttmacher Institute and UNFPA, NY, USA (2009).
  • Sonfield A. Popularity disparity: attitudes about the IUD in Europe and the United States. Guttmacher Policy Review. 10(4), 19–24 (2007).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.